<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00734448</url>
  </required_header>
  <id_info>
    <org_study_id>Myo-1954</org_study_id>
    <nct_id>NCT00734448</nct_id>
  </id_info>
  <brief_title>Myo-inositol Administration in Gestational Diabetes</brief_title>
  <official_title>Effect of Myo-inositol Administration on Insulin Sensitivity in Gestational Diabetes Patients by Continuous Glucose Monitoring System (CGMS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myo-Inositol is an insulin sensitizing agent that ameliorate the insulin resistance in women
      affected by gestational diabetes (GDM), but there is no information about the effect on the
      glucose profile. Maternal hyperglycemia of GDM, especially hypoglycemic excursions, are
      associated with adverse pregnancy outcome. Continuous Glucose Monitoring System (CGMS) is
      obviously better than intermittent self monitoring in detecting glucose profile and magnitude
      and duration of glucose fluctuations. For this reason, we propose a clinical trial to analyze
      the characteristics of glucose variability in GDM women,treated with diet and folic acid
      alone or with diet, folic acid and myo-inositol supplementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our study is a randomized, prospective, controlled trial, including the first 30 consecutive
      Caucasian gestational diabetes patients diagnosed,according the International Association of
      Diabetes and Pregnancy Study Group (IADPSG) panel criteria, from November 2013 in the
      Department of Obstetric and Gynecology of Messina University (ITALY). After an informed
      consent they will be randomly assigned to receive (n. 15) diet and folic acid (400 mcg per
      day) alone or (n. 15) diet, folic acid (400 mcg per day) and myo-inositol (2 g. twice a
      day)supplementation. The insulin sensitivity index (HOMA-IR) and the glycemic profile will be
      monitor by CGMS for each patient at GDM diagnosis and after 8 weeks of treatment The pregnant
      women who will delivery before the time treatment (8 weeks) or who need insulin will be
      excluded.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity index (HOMA-IR) and continuous glucose monitoring profile</measure>
    <time_frame>Change from baseline in HOMA-IR at 8 weeks of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>baby weight at delivery</measure>
    <time_frame>After delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gestational Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>A,1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gestational diabetes patients who take myo-inositol</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>myo-inositol</intervention_name>
    <description>2 g twice a day until delivery</description>
    <arm_group_label>A,1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational diabetes diagnosed within 28 weeks

          -  Caucasian pregnant women

        Exclusion Criteria:

          -  Non Caucasian pregnant women

          -  Delivery before 8 weeks of treatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosario D'Anna, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Messina, ITALY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>rosario d'anna, professor</last_name>
    <phone>39-090-2211</phone>
    <phone_ext>3809</phone_ext>
    <email>rosariodanna@tin.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Messina -</name>
      <address>
        <city>Messina</city>
        <state>Sicilia</state>
        <zip>98100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>francesco corrado, researcher</last_name>
      <phone>39-090-2211</phone>
      <phone_ext>2176</phone_ext>
      <email>francesco.corrado@unime.it</email>
    </contact>
    <investigator>
      <last_name>rosario d'anna, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>francesco corrado, researcher</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2008</study_first_submitted>
  <study_first_submitted_qc>August 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2008</study_first_posted>
  <last_update_submitted>June 12, 2014</last_update_submitted>
  <last_update_submitted_qc>June 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Rosario D'anna</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>gestational diabetes mellitus</keyword>
  <keyword>carbohydrate intolerance</keyword>
  <keyword>myo-inositol</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inositol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

